Recent Updates
Recently added Catalysts
RLAY Neutral Sentiment

Relay Therapeutics to Announce Second Quarter 2023 Financial Results and Corporate Highlights on August 8, 2023

Tuesday, August 1, 2023 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Relay Therapeutics, a clinical-stage precision medicine company, will announce its second quarter 2023 financial results and corporate highlights on August 8, 2023. The announcement will occur after the U.S. financial markets close. This report is anticipated to provide insights into the company’s current performance and future direction as it relies on advanced drug discovery technologies.
Price reaction · baseline $12.6 (2023-07-31 close) · hit after-hours · clean, no other RLAY news in the window
day 0 close
-5.5%
day 1
-9.2%
day 3 · peak
-10.7%

Market Sentiment Analysis

POSITIVE FACTORS

  • Relay Therapeutics is actively reporting its financial results, indicating transparency.
  • The company's use of advanced computational and experimental technologies reflects innovation in drug discovery.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+284%
120-day peak, hindsight
Typical move
11.8%
average across 6 past catalysts
Cash runway
~50 mo
Minimal dilution risk
Lead asset
RLY-8161
Phase 1 · Advanced NRAS-Mutant Melanoma

Full Press Release Details

CAMBRIDGE, Mass., Aug. 01, 2023 (GLOBE NEWSWIRE) -- Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies, will report second quarter 2023 financial results and corporate highlights after the U.S. financial markets close on Tuesday, August 8, 2023.
About Relay Therapeutics

Frequently Asked Questions

When will Relay Therapeutics report its Q2 2023 financial results?

Relay Therapeutics will report its Q2 2023 financial results on August 8, 2023.

What is Relay Therapeutics focused on?

Relay Therapeutics focuses on transforming drug discovery through advanced technologies.

Where is Relay Therapeutics located?

Relay Therapeutics is based in Cambridge, Massachusetts.

How can I contact Relay Therapeutics?

You can contact Relay Therapeutics at mgoulart@relaytx.com.

ShareAdd on Google
Tags: RLAY Viatris Investor Conferences Healthcare Relay Therapeutics financial results second quarter 2023 drug discovery Cambridge
Last updated: Aug 1, 2023

Biotech snapshot

Cash runway
$911M liquidity · $18M/mo burn
~50 mo
Minimal dilution risk
Lead asset
RLY-8161Phase 1
Advanced NRAS-Mutant Melanoma →

Catalyst track record

+284%
best trade around RLAY's most recent catalyst

Peak hindsight return over a 120-day window, across 6 tracked FDA/PDUFA catalysts for RLAY.

See every catalyst's timing & PoA →